Track artwork

Statins: benefits and harms for low risk patients

BMJ talk medicine on October 25, 2013 16:09

0.00 / 19.28
Hide the comments

Stats for this track

This Week Total
Plays 6521
Favoritings 9

Uploaded by

  • Report copyright infringement

    In 7 Sets

    View all

    More tracks by BMJ talk medicine

    "Is climbing Everest good for my heart, doctor?"

    Assoc Prof Kay Crossley on procedures for patellofemoral pain

    Mortality on match days of the German national soccer team

    Managing muscle injuries – Does the Munich Consensus Statement help? Part 2 of 2

    Managing the difficult ankle and foot with Prof Gino Kerkhoffs - Part 1 of 2

    View all

    NB: In our interview about statins, Abramson quotes the figure of an 18% relative increase in risk of adverse effects of statins. This figure should be couched in uncertainty, and a correction has been posted on to reflect that -
    It may soon be recommended that statins are prescribed to patients with a low risk of cardiovascular disease. John Abramson from the Department of Health Care Policy at Harvard Medical School explains why the risks associated with taking the drug may have been underplayed.

    Also this week, interviews with Steve Field, the new chief inspector of hospitals, and Richard Vautry, deputy chairman of the BMA's GP committee, recorded at the National Association of Primary Care's annual Best Practice conference.

    See also:
    Should people at low risk of cardiovascular disease take a statin?

    Add a new comment

    You need to be logged in to post a comment. If you're already a member, please or sign up for a free account.

    Share to

    If you are using self-hosted WordPress, please use our standard embed code or install the plugin to use shortcodes.
    Add a comment 0 comments at 0.00
      Click to enter a
      comment at